Oyster Point Pharma, Inc. (OYST) Minute Stock Prediction

About:

Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ocular surface diseases in the United States. The company’s lead product candidate is OC-01, a nicotinic acetylcholine receptor agonist that has completed Phase III clinical trial for the treatment of signs and symptoms of dry eye disease. It is also developing OC-01 for neurotrophic keratopathy. Oyster Point Pharma, Inc. was incorporated in 2015 and is headquartered in Princeton, New Jersey.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

62

Address:

Oyster Point Pharma, Inc. 202 Carnegie Center Suite 109 Princeton NJ 08540 United States

Website:

Home

Phone:

609-382-9032